Literature DB >> 10730437

[An epidemic outbreak of mumps. A study of vaccinal efficacy].

B López Hernández1, R M Martín Vélez, C Román García, I Peñalver Sánchez, J A López Rosique.   

Abstract

OBJECTIVE: Description of an outbreak of mumps in an urban area. Study of the effectiveness of the mumps component of the triple virus (TV) vaccination.
DESIGN: Cross sectional descriptive study of the outbreak. The cases were obtained from the Andalusian Register of Infectious Diseases (SVEA in Spanish). The effectiveness of the vaccine was studied through a retrospective cohort design, with the cohorts defined according to their vaccination history.
SETTING: Urban area of low social class and income and young population pyramid. The outbreak occurred between March and November 1997. The effectiveness of vaccination at one school was studied. PATIENTS AND OTHER PARTICIPANTS, RESIDENTS IN THE AREA: The source of the population was the 1996 municipal census.
INTERVENTIONS: The declared cases of mumps were taken from the SVEA. The state of vaccination was documented through a review of the school registration records, vaccination cards and the health centre register of names.
MEASUREMENTS AND MAIN RESULTS: A total of 283 cases of mumps were declared. There were more cases in the 0-10 age group than at older ages. 79% of cases were vaccinated (95% CI, 74.3-73.7). Effectiveness of a dose of the mumps component of the vaccine was low (46%; CI, 0-84), though the effectiveness of a second dose was higher (87%; CI, 27-99).
CONCLUSIONS: The low effectiveness of the mumps component of the TV vaccination was confirmed. It is proposed that the age for the second dose should be brought forward to school-starting age (primary, first year). Ensuring school vaccination is recommended.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10730437     DOI: 10.1016/s0212-6567(00)78478-2

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  6 in total

1.  [Study of a population-wide epidemic outbreak of mumps virus G1 in Jerez de la Frontera (Spain)].

Authors:  Pascasio Peña González; José Almenara Barrios; Juan Carlos Morales Serna
Journal:  Aten Primaria       Date:  2011-10-21       Impact factor: 1.137

2.  [Mumps in a urban area of the Community of Madrid. Vaccination status, diagnosis and intervention measures].

Authors:  R de los Ríos Martín; N García Marín; J Sanz Moreno; E Ballester Orcal
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

Review 3.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

4.  Matched case-control study of effectiveness of live, attenuated S79 mumps virus vaccine against clinical mumps.

Authors:  Chuanxi Fu; Jianhua Liang; Ming Wang
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

5.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

6.  Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population.

Authors:  Anand A Date; Moe H Kyaw; Alison M Rue; Julie Klahn; Leann Obrecht; Terry Krohn; Josh Rowland; Steve Rubin; Thomas J Safranek; William J Bellini; Gustavo H Dayan
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 7.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.